The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

On Thursday, the Food and Drug Administration (FDA) announced that Avandia will only be prescribed to patients with Type 2 diabetes that cannot be controlled with other diabetes medications.

Avandia has been under fire because of its link to increased risks of cardiovascular events, such as heart and stroke. In addition to the FDA’s announcement, the European Medicines Agency (EMA), the European counterpart to the FDA, recommended on Thursday that Avandia be completely removed from the market. The FDA said that it will require that GlaxoSmithKline (GSK), the manufacturer of Avandia, create a restricted access program for Avandia under a risk evaluation and mitigation strategy (REMS).

Sheller, P.C. is handling Avandia cases. If you or a loved one has suffered a heart attack or stroke while taking Avandia, please contact our office at 1-800-883-2299.

Comments are closed.

Of Interest